Enhanced Molecular Mobility of Ordinarily Structured Regions Drives Polyglutamine Disease

被引:22
作者
Lupton, Christopher J. [1 ]
Steer, David L. [1 ]
Wintrode, Patrick L. [3 ]
Bottomley, Stephen P. [1 ]
Hughes, Victoria A. [1 ,2 ]
Ellisdon, Andrew M. [1 ]
机构
[1] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia
[2] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Melbourne, Vic 3800, Australia
[3] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
基金
英国医学研究理事会;
关键词
MACHADO-JOSEPH-DISEASE; PROTEIN AGGREGATION; MASS-SPECTROMETRY; FUNCTIONAL INTERACTIONS; HYDROGEN-EXCHANGE; MUTANT HUNTINGTIN; ATAXIN-3; DOMAIN; PATHOGENESIS; DETERMINANTS;
D O I
10.1074/jbc.M115.659532
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyglutamine expansion is a hallmark of nine neurodegenerative diseases, with protein aggregation intrinsically linked to disease progression. Although polyglutamine expansion accelerates protein aggregation, the misfolding process is frequently instigated by flanking domains. For example, polyglutamine expansion in ataxin-3 allosterically triggers the aggregation of the catalytic Josephin domain. The molecular mechanism that underpins this allosteric aggregation trigger remains to be determined. Here, we establish that polyglutamine expansion increases the molecular mobility of two juxtaposed helices critical to ataxin-3 deubiquitinase activity. Within one of these helices, we identified a highly amyloidogenic sequence motif that instigates aggregation and forms the core of the growing fibril. Critically, by mutating residues within this key region, we decrease local structural fluctuations to slow ataxin-3 aggregation. This provides significant insight, down to the molecular level, into how polyglutamine expansion drives aggregation and explains the positive correlation between polyglutamine tract length, protein aggregation, and disease severity.
引用
收藏
页码:24190 / 24200
页数:11
相关论文
共 46 条
[1]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[2]   The role of dynamic conformational ensembles in biomolecular recognition [J].
Boehr, David D. ;
Nussinov, Ruth ;
Wright, Peter E. .
NATURE CHEMICAL BIOLOGY, 2009, 5 (11) :789-796
[3]   The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity [J].
Burnett, B ;
Li, FS ;
Pittman, RN .
HUMAN MOLECULAR GENETICS, 2003, 12 (23) :3195-3205
[4]   Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation [J].
Chen, SM ;
Ferrone, FA ;
Wetzel, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11884-11889
[5]   Amyloid-like features of polyglutamine aggregates and their assembly kinetics [J].
Chen, SM ;
Berthelier, V ;
Hamilton, JB ;
O'Nuallain, B ;
Wetzel, R .
BIOCHEMISTRY, 2002, 41 (23) :7391-7399
[6]   Amyloid formation by globular proteins under native conditions [J].
Chiti, Fabrizio ;
Dobson, Christopher M. .
NATURE CHEMICAL BIOLOGY, 2009, 5 (01) :15-22
[7]   Polyglutamine expansion in ataxin-3 does not affect protein stability - Implications for misfolding and disease [J].
Chow, MKM ;
Ellisdon, AM ;
Cabrita, LD ;
Bottomley, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (46) :47643-47651
[8]   Trinucleotide repeats: Mechanisms and pathophysiology [J].
Cummings, CJ ;
Zoghbi, HY .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2000, 1 :281-328
[9]   Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model [J].
Cushman-Nick, Mimi ;
Bonini, Nancy M. ;
Shorter, James .
PLOS GENETICS, 2013, 9 (09)
[10]   Flanking polyproline sequences inhibit β-sheet structure in polyglutamine segments by inducing PPII-like helix structure [J].
Darnell, Gregory ;
Orgel, Joseph P. R. O. ;
Pahl, Reinhard ;
Meredith, Stephen C. .
JOURNAL OF MOLECULAR BIOLOGY, 2007, 374 (03) :688-704